MYCELX Ebitda from 2010 to 2024
| MYX Stock | 37.50 0.00 0.00% |
EBITDA | First Reported 2008-01-31 | Previous Quarter -795.5 K | Current Value -795.5 K | Quarterly Volatility 599.9 K |
Check MYCELX Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MYCELX Technologies' main balance sheet or income statement drivers, such as Depreciation And Amortization of 963.5 K, Interest Expense of 2.2 K or Selling And Marketing Expenses of 7.3 M, as well as many indicators such as . MYCELX financial statements analysis is a perfect complement when working with MYCELX Technologies Valuation or Volatility modules.
MYCELX | Ebitda |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in MYCELX Stock
MYCELX Technologies financial ratios help investors to determine whether MYCELX Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in MYCELX with respect to the benefits of owning MYCELX Technologies security.